The global aesthetic medicine market size is expected to reach USD 149.06 Billion in 2030 and register a revenue CAGR of 9.9% over the forecast period, according to the latest report by Reports and Data. Increasing inclination toward enhancing facial and bodily aesthetic appearance along with advancements in surgical as well as non-surgical aesthetic treatments is driving aesthetic...

The Enzyme inhibitors Market 2026 report provides detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Enzyme inhibitors market players, value chain optimization, trade regulations, recent developments, opportunities analysis,...

MPS IV (Morquio syndrome) Market provides in-depth analysis of global, regional and country-level markets, segmentation growth, market share, competitive landscape, sales analysis, impact of global and domestic MPS IV (Morquio syndrome) Market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis,...

The Peptide Therapeutics Market in 2023 is US$ 44.79 billion, and is expected to reach US$ 74.24 billion by 2031 at a CAGR of 6.50%. FutureWise Research published a report that analyzes Peptide Therapeutics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market...

The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides have gained a wide range of applications in medicine and biotechnology. In the last five years (2015–2019), the US Food Drug Administration (FDA) has authorized a total of 208 new drugs, 15 of which were peptides or peptide-containing molecules, which...

With the advent of novel technologies and rising preference for such therapeutic interventions, biologics have made a significant impact in the pharmaceutical domain, delivering a ground-breaking treatment regimen for a myriad of disease indications.   London Roots Analysis has announced the addition of the “Biopharmaceutical Contract Manufacturing Market, 2022–2035”...